DRG Market Assessment reports
Access comprehensive market intelligence covering Disease Landscape & Forecast, Epidemiology Intelligence, Biosimilars Intelligence, China In-depth and more.
Biosimilars | Market Events and Forecast Landscape – Overview of Biosimilar Forecasts | 2023
In 2021, sales of branded biologics in oncology, immunology, endocrinology, nephrology, respiratory, and ophthalmology exceeded $130 billion in the major pharmaceutical markets under study (United…
Biosimilars | Market Events and Forecast Landscape – Forecast Methodology and General Market Assumptions | 2023
In 2021, sales of branded biologics for oncology, immunology, endocrinology, nephrology, respiratory, and ophthalmology indications exceeded $130 billion in the major pharmaceutical markets under…
Metabolic Dysfunction-Associated Steatohepatitis – Epidemiology – Extrapolated Worldwide Coverage
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key non-alcoholic steatohepatitis patient populations, covering 171…
Metabolic Dysfunction-Associated Steatohepatitis – Epidemiology – Epidemiology Dashboard
Clarivate Epidemiology’s coverage of NASH comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the total NASH prevalent cases for each country, as…
